Second-line Regimen Combined With Radiotherapy Versus Without Radiotherapy in Patients With Locally Advanced/Oligometastatic ICC After Failure of First-line Treatment：an Open-label, Randomized, Controlled Phase II Clinical Study
Clinical trial NCT06946849 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06946849
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-01
- Primary completion
- 2027-05-31
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.